Shares of $MNKD continue to drop after CRL
publication date: Jan 28, 2011
Last week MNKD recieved a CRL causing shares to drop about 25%. This drop was not nearly as severe as I had expected, especially considering the long path ahead for MNKD. Multiple clinical trials as well as possible dilution. I was expecteing to see MNKD immediately trading in the $4 range, possibly as low as the mid $3's. When shares only dipped into the $5's and bounced to the $6's I re-read the press releases and looked for a possible reason why share price was holding up so well- in fact they were stayin in the bottom range of the run-up.